NFG
UTHR icon

Nations Financial Group’s United Therapeutics UTHR Stock Holding History

Nations Financial Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.44M Buy
4,116
+72
+2% +$35.9K 0.13% 189
2025
Q4 		$1.97M Buy
4,044
+524
+15% +$244K 0.1% 210
2025
Q3 		$1.48M Buy
3,520
+509
+17% +$171K 0.09% 237
2025
Q2 		$865K Buy
3,011
+77
+3% +$23K 0.06% 320
2025
Q1 		$904K Buy
2,934
+11
+0.4% +$3.77K 0.07% 294
2024
Q4 		$1.03M Buy
2,923
+19
+0.7% +$6.98K 0.08% 266
2024
Q3 		$1.04M Buy
2,904
+136
+5% +$45.9K 0.08% 271
2024
Q2 		$882K Buy
2,768
+1,329
+92% +$352K 0.07% 284
2024
Q1 		$331K Buy
1,439
+398
+38% +$89.8K 0.03% 513
2023
Q4 		$229K Buy
+1,041
New +$240K 0.02% 569

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Nations Financial Group's UTHR Position: Q1 2026 in Review

Nations Financial Group increased its United Therapeutics (UTHR) stake by 1.8% in Q1 2026, buying an estimated $35.9K and bringing the position to 4,116 shares worth $2.44M. The position accounts for 0.13% of the portfolio, ranked #189.

Nations Financial Group first reported a position in UTHR in Q4 2023 and has held it in 10 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Nations Financial Group held 4,116 shares of United Therapeutics worth $2.44M as of Q1 2026.
  • Nations Financial Group bought 72 United Therapeutics shares in Q1 2026, an estimated $35.9K.
  • United Therapeutics made up 0.13% of Nations Financial Group's portfolio in Q1 2026, its #189 holding.
  • Nations Financial Group first reported a position in United Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Nations Financial Group's 13F filing for Q1 2026, filed 15 Apr 2026.